Testing the Combination of Belinostat and SGI-110 (Guadecitabine) for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma

Conditions:   Metastatic Primary Central Chondrosarcoma;   Unresectable Primary Central Chondrosarcoma Interventions:   Drug: Belinostat;   Drug: Guadecitabine Sponsor:   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials